Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Ivosidenib in IDH1-mutant, Chemotherapy-Refractory Cholangiocarcinoma (claridhy): a Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study

Ghassan K. Abou-Alfa,Teresa Macarulla,Milind M. Javle,Robin K. Kelley,Sam J. Lubner,Jorge Adeva,James M. Cleary,Daniel V. Catenacci,Mitesh J. Borad,John Bridgewater,William P. Harris,Adrian G. Murphy,Do-Youn Oh,Jonathan Whisenant,Maeve A. Lowery,Lipika Goyal,Rachna T. Shroff,Anthony B. El-Khoueiry,Bin Fan,Bin Wu,Christina X. Chamberlain,Liewen Jiang,Camelia Gliser,Shuchi S. Pandya,Juan W. Valle,Andrew X. Zhu

SSRN Electronic Journal（2019）

Cited 717|Views155
Key words
Intrahepatic Cholangiocarcinoma,Cholangiocarcinoma,Cancer Progression
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined